Neuro Flashcards
(229 cards)
1
Q
Acute Neuronal Injury
A
- changes secondary to hypoxia/**ischemia **⇒ cell necrosis or apoptosis.
- intense cytoplasmic eosinophilia and nuclear pyknosis = red neurons
2
Q
Subacute and Chronic Neuronal Injury
A
- degeneration = neuronal death and reactive gliosis
- trans-synpatic degeneration when afferent inputs to neuron are lost.
3
Q
Axonal Reaction
A
- response of neuronal cell body to challenge of regenerating damaged axons.
- cell body rounds up and nucleoli enlarge.
- Nissl substance dispersal and perinuclear cytoplasmic pallor (central chromatolysis) = ↑ protein synthesis and axonal sprouting
4
Q
Neuronal Inclusions
A
- manifestation of aging (lipofuscin), disorders of metabolism (storage material), viral diseases (inclusion bodies), or neurodegenerative diseases with aggregated proteins.
5
Q
Astrocytes
A
- principal cells for repair and scar formation in brain.
- important for blood brain barrier.
- with CNS damage, get enlarged vesicular nuclei and conspicuous eosinophilic cytoplasm (gemistocytic astrocytes)
- astrocyte hypertrophy and hyperplasia ⇒ gliosis
-
directly injured ⇒ rosenthal fibers, corpora amylacea, alzheimer type II astrocytes.
- rosenthal fibers = elongated, eosinophilic structure in astrocyte processes containing alphaB-crystallin and hsp27. see in long-standing gliosis or pilocytic astrocytomas.
- corpora amylacea = lamellated polyglucosan bodies and hsp. ↑ with age, are degenerative change.
- Alzheimer type II astrocytes = enlarged nucleus with intranuclear glycogen and pale chromatin. occurs with hyperammonemia.
6
Q
Glial Cell Injury
A
- oligodendroglial cell apoptosis feature of demyelinating disorders and leukodystrophies.
- viral inclusions in progressive multifocal leukoencephalopathy
- alpha-synuclein inclusions in multiple system atrophy (MSA)
- ependymal cells don’t regenerate. damage ⇒ proliferation of subependymal astrocytes = ependymal granulations
7
Q
Cerebral Edema
A
-
vasogenic = ↑ vascular permeability ⇒ accumulate intercellular fluid.
- focal or generalized.
- absence of lymphocytes impairs resorption.
- cytotoxic = ↑ intracellular fluid 2° to endothelial, neuronal, or glial injury.
- interstitial = fluid from ventricular system transudates across ependyal lining from ↑ intraventricular pressure.
8
Q
Hydrocephalus
A
- obstruction of CSF flow ⇒ ventricular enlargement and ↑ CSF volume
- from impaired flow or resorption, overproduction uncommon.
- occurs prior to cranial suture closure ⇒ enlarged head.
- occurs after cranial suture closure ⇒ ventricular expansion and ↑ ICP
- non-communicating = enlargement of a portion of the ventricle system.
- communicating = entire system expanded
- hydrocephalus ex vacuo = extensive tissue loss ⇒ compensatory expansion of entire CSF compartment
9
Q
Subfalcine Herniation
A
- aka cingulate herniation.
- from ↑ ICP.
- can compromise branches of anterior cerebral artery.
10
Q
Transtentorial Herniation
A
- aka uncinate, mesial temporal herniation.
- distorts adjacent midbrain and pons.
- 3rd CN compromise ⇒ pupillary dilation
- compression of posterior cerebral artery ⇒ ipsilateral hemiparesis
- Duret hemorrhages = tearing of feeding vesels.
11
Q
Tonsillar Herniation
A
- through foramen magnun ⇒ compress medulla and compromise cardiac and respiratory centers.
12
Q
Neural Tube Defects
A
- primary failure to close or secondary reopening.
- abnormalities in some combo of neural tissue, meninges, and ovelrying bone and soft tissues.
- risk factors: folate deficiency.
- antenatal diagnosis through alpha-fetoprotein screening.
- encephalocele, anencephaly, spina bifida, myelomeningocele.
13
Q
Encephalocele
A
- malformed CNS diverticulum extending through defect in cranium (occiput or posterior fossa)
14
Q
Anencephaly
A
- malformation of anterior neural tube ⇒ failure of cerebrum development
15
Q
Spina Bifida
A
- occulta = asymptomatic bony defect
- or a severe malformation with flattened, disorganized cord segment with overlying meningeal outpouching.
16
Q
Myelomeningocele
A
- CNS outpouching through vertebral column defect.
- mostly lumbrosacral region with lower extremity motor and sensory deficits and disturbed bowel and bladder control.
17
Q
Forebrain Anomalies
A
- issues with brain size: microencephaly, lissencephaly, agyria, megalencephaly.
- issues with gyral formation and organization: polymicrogyria, neuronal heterotopias, holoprosencephaly, agenesis of corpus callosum.
18
Q
Microencephaly
A
- small brain.
- too many periventricular cells proliferate too soon.
- from chromosomal abnormalities, fetal alcohol syndrome, in uter HIV.
19
Q
Lissencephaly
A
- aka agyria.
- smooth brain, few to no gyri.
- too many periventricular cells proliferate too soon.
- from chromosomal abnormalities, fetal alcohol syndrome, in utero HIV.
20
Q
Megalencephaly
A
- large brain.
- too few periventricular cells proliferate at early stages ⇒ overproduction of neurons.
21
Q
Polymicrogyria
A
- small, overabundant cerebral convolutions from focal injury near end of neuronal migration.
22
Q
Neuronal Heterotopias
A
- abnormal clusters of neurons in inappropriate locations along normal migratory routes.
- associated with epilepsy.
- mutations in filamin A or microtubule associated proteins.
23
Q
Holoprosencephaly
A
- incomplete separation of cerebral hemispheres.
- midline facial abnormalities (cyclopia).
- mutation of sonic hedgehog or other genes in neural development.
24
Q
Agenesis of Corpus Callosum
A
- normal white matter interhemispheric bundles not formed.
- may have mental retardation but clinically most are normal.
25
**Posterior Fossa Anomalies**
* **Dandy-Walker Malformation**
* **Arnold-Chiari Malformation **
* **Chiari I malformation**
26
**Dandy-Walker Malformation**
* enlarged posterior fossa, absent cerebellar vermis, large midline cyst with brainstem nuclei dysplasias.
27
**Arnold-Chiari Malformation**
* aka Chiari II malformation
* small posterior fossa, malformed midline cerebellum, extension of vermis through foramen magnum, hydrocephalus, lumbar myelomeningocele.
28
**Chiari I Malformation**
* low-lying cerebellar tonsils extend into vertebral canal.
* clinically silent but can present with CSF flow obstruction.
29
**Syringomyelia**
* formation of **cleftlike cavity in spinal cord**.
* _morphology_: gray and white matter destruction surrounded by reactive gliosis.
* **_presentatio_**n: **loss of pain and temperature** sensation in **upper extremities.**
30
**Hydromyelia**
* **expansion of central canal**.
* _morphology_: gray and white matter destruction surroudned by reactive gliosis.
* _presentation_: **loss of pain and temperature** sensation in **upper extremities.**
31
**Perinatal Brain Injury**
* **non-aggressive motor deficits** from pre- and perinatal neurologic insults.
* risk factor: **prematurity**.
* can have brain injury without reactive gliosis.
* intraparenchymal hemorrhage, periventricular leukomalacia, multicystic encephalopathy, ulegyria, status marmoratus.
* _presentation_: depends on location but includes **dystonia, spasticity, ataxia/athetosis, and/or paresis**
32
**Perinatal Intraparenchymal Hemorrhage**
* in germinal matrix btw thalamus and caudate nucleus. can extend to ventricular system.
33
**Periventricular Leukomalacia**
* ischemic infarcts in periventricular white matter.
34
**Multicystic Encephalopathy**
* ischemic infarcts within the hemispheres.
35
**Ulegyria**
* thin, gliotic gyri from perinatal cortical ischemia.
36
**Status Marmoratus**
* ischemic neuronal loss and gliosis in basal ganglia and thalamus with aberrant and irregular myelin formation.
37
**Skull Fractures**
* fracture resistance varies with skull bone thickness.
* **displaced fracture** = bone shifts into cranial vault by more than its thickness.
* **accidental falls** = occiput. 2° basal skull involved with lower CN or cervicomedullary symptoms, CSF discharge, and/or meningitis.
* **syncope** ⇒ frontal skull.
* **diastatic fractures** = transverse sutures.
38
**Concussion**
* **transient trauma-related** clinical syndrome with **loss of consciousness, temporary respiratory arrest, loss of reflexes, amnesia** of event.
39
**Direct Parenchymal Injury (Brain)**
* **lacerations** = penetrating injury causes tissue tearing.
* **contusions** = CNS bruises.
* gyral crest very susceptible.
* **coup** contusion = at site of impact
* **contrecoup** = on opposite side of cranium from impact
* brain hemorrhage and edema resolves ⇒ depressed, yellow-brown glial scar going to pial surface = **plaque jaune**
40
**Diffuse Axonal Injury**
* when **mechanical forces** (acceleration) **disrupt axonal integrity and axoplasmic flow.**
* **widespread axonal swelling and focal hemorrhage ⇒ degenerated fibers and gliosis**.
* 1/2 pts comatose after trauma have diffuse axonal injury even without contusions.
41
**Epidural Hematoma**
* rupture of **dural arteries (middle meningeal artery) **⇒ blood **btw dura and skull ⇒ compress brain**.
* can have **lucid period** several hours after trauma
42
**Subdural Hemorrhage**
* **tearing of veins that stretch from cortical surface through subarachnoid and subdural spaces into draining veins** (superior sagittal sinus).
* after traumatic shifting of brain.
* **geriatric pts** with cerebral atrophy susceptible.
* _presentation_: non-localizing headache, confusion within 48hrs of injury.
* **_chronic subdural hematoma_** = recurrent episodes of bleeding **from hemorrhage of thin-walled vessels of granulation tissue**.
* _tx_: surgical drainage and remove granulation tissue.
43
**Sequelae of Brain Trauma**
* **epilepsy, meningiomas, infectious disease, psychiatric disorders**.
* **_post-traumatic hydrocephalus_** = hemorrhage into subarachnoid space obstructs CSF resorption
* **_post-traumatic dementia_** = **dementia pugilistica**. repeated head trauma ⇒ hydrocephalus, corpus callosum thinning, diffuse axonal injury, amyloid plaques, and neurofibrillary tangles.
44
**Spinal Cord Trauma**
* displacement of spinal column.
* injury level:
* **thoracic vertebrae** or below ⇒ **paraplegia**.
* **cervical vertebrae ⇒ quadriplegia**.
* **_C4 and above_** ⇒ **respiratory compromise** from diaphragm paralysis.
* _acute_ = **hemorrhage, necrosis, white matter axonal swellings**
* _later_ = **cystic and gliotic**. ascending and descending white matter tracts do 2° **degeneration**.
45
**Global Cerebral Ischemia**
* hypoxia from reduced blood flow or hypotension.
* **neurons more sensitive** to hypoxia.
* **severe ⇒ widespread neuronal cell death**, pt vegetative state or brain dead.
* brain dead = flat EEG, absent reflexes/respiratory drive/cerebral perfusion
* kept on ventilator ⇒ brain autolyzes.
* **watershed/border zone infarcts** = oxygenation incompletely compromised. interface between major vessels.
* btw **anterior and middle cerebral arteries** most vulnerable.
* _morphology_: edematous with **widened gyri and narrowed sulci**. **poor gray/white demarcation**.
* **red neurons 12-24hrs post injury**. pyramidal neurons in hippocampus CA1 (Sommer sector), cerebellar Purkinje cells, cortical pyramidal neurons most susceptible.
* then **neutrophil infiltration ⇒ macrophage influx, neovascularization, reactive gliosis**.
* **pseudolaminar necrosis** = uneven cortical neuronal loss and gliosis alternating with preserved zones.
46
**Stroke**
* brain oxygen deprivation from **global or focal ischemic necrosis**.
* outcome **depends on collateral circulation, duration of ischemia, magnitude and rapidity of flow reduction**.
47
**Focal Cerebral Ischemia**
* **infarction from obstruction of local blood supply ⇒ thrombotic or embolic arterial occlusion**.
* **thrombosis** = from atherosclerosis. affects extracerebral **carotid system and basilar artery**.
* **embolism** = involves intracerebral arteries (**middle cerebral**). comes from atheromatous cerebrovascular plaques, cardiac mural trhombi, valvular lesions, or paradoxical embolisms.
* **inflammatory lesions** can ⇒ lumenal narrowing and cerebral infarct.
* **venous infarcts** after occlusion of **superior sagittal sinus or deep cerebral veins**. are hemorrhagic.
* _morphology_: **_nonhemorrhagic infarcts_** = bland/anemic infarcts. **see at 48hrs** as **pale, soft regions of edematous brain with neutrophils**. then liquefies ⇒ **fluid-filled cavity with macrophages lined by reactive glia**.
* **_hemorrhagic infarcts_** = **embolic occlusion with reperfusion injury**, have **blood extravasation**.
48
**Lacunar Infarcts**
* **small cystic infarcts from cerebral arteriolar sclerosis and occlusion**.
* **lipid-laden macrophages** and surrounding gliosis.
* affects: lenticular nucleus, thalamus, internal capsule, deep white matter, caudate nucleus, and pons.
49
**Slit Hemorrhages**
* when **HTN causes small vessel rupture**.
* they resorb leaving **hemosiderin-laden macrophages** and gliosis.
50
**Acute Hypertensive Encephalopathy**
* **↑ ICP ⇒ diffuse cerebral dysfunction** (headaches, confusion, vomiting, convulsions, coma).
* need rapid intervention.
* post mortem shows **edematous brain with petechiae and arteriolar fibrinoid necrosis**. somtimes see herniation.
51
**Chronic Hypertensive Injury**
* **recurrent small infarcts ⇒ vascular (multi-infarct) dementia**
* dementia, gait abnormalities, pseudobulbar signs, focal neuro deficits.
* **_Binswanger disease_** = pattern of recurrent ischemic injury involves **subcortical white matter with myelin and axonal loss**.
52
**Intracerebral Hemorrhage**
* spontaneous **rupture of small intraparenchymal vessel**.
* age **\>60yrs**.
* causes:
* **_HTN_** in 50%. ⇒ hyaline arteriosclerosis and **vessel weakening, focal vessel necrosis, Charcot-Bouchard aneurysms**. in **putamen** (50-60%), thalamus, pons, cerebellar hemispheres.
* cerebral amyloid angiopathy **_(CAA)_**: 2nd most common. ** amyloidogenic peptides deposited in vessel walls** ⇒ weakening. lesions have **stiff amyloid deposits in leptomeningeal and cerebral cortical vessels**.
* cerebral autosomal dominanty arteriopathy with subcortical infarcts **_(CADASIL)_**: **mutation in Notch3 receptor**. vessels have **concentric medial and adventitial thickening** with **basophilic granular depostis and smooth muscle drop-out**
53
**Subarachnoid Hemorrhage**
* usually **from berry (saccular) aneurysm rupture**, traumatic hematomas, vascular malformations, HTN intracerebral hemorrhage, tumors, hematologic disturbances.
* _pathogenesis_: 90% berry aneurysms in anterior circulation near arterial branch points.
* can be with polycystic kidney disease (autosomal dominant), HTN, aortic coarctation, collagen disorders, neurofibromatosis type I, and fibromuscular dysplasia
* _morphology_: small with **red shiny translucent wall**. at aneurysm neck, the muscular wall and intimal elastic lamina are absent. **sac wall is only thickened hyalinized intima**.
* _presentation_: **rupture from ↑ ICP**. **excruciating headache, rapid loss of consciousness**. re-bleeding common with worse episode each time the aneurysm bleeds.
* **blood in subarachnoid ⇒ arterial vasospasm**.
* blood resorption ⇒ **meningeal fibrosis and hydrocephalus**
54
**Arteriovenous Malformation**
* **tangles of abnormalled tortuous and misshapen vessels, shunting arterial blood into venous circulation**.
* usually **MCA**.
* 2:1 m:f
* _presentation_: btw ages **10-30yrs** as **seizure disorder, intracerebral hemorrhage, or subarachnoid hemorrhage**
55
**Cavernous Hemangiomas**
* **distended, loosely organized vascular channels with thin, collagenized walls**.
* usually cerebellum, pons, and subcortical regions.
* **low flow without arteriovenous shunting.**
56
**Capillary Telangiectasias**
* **microscopic foci of dilated, thin-walled vascular channels separated by normal brain parenchyma**.
* in **pons**.
57
**Venous Angiomas**
* aka varices
* **aggregates of ecstatic veins**.
58
**Foix-Alajouanine Disease**
* **venous angiomatous malformation in lumbosacral region**.
* slowly progressive ischemia and neuro symptoms.
59
**Acute Bacterial Meningitis**
* neonates = **E. coli and group B strep**
* infants & kids = **S. pneumoniae**
* adolescents & young adults = **N. meningitidis**
* elderly = **S. pneumoniae and L. monocytogenes**
* _morphology_: **meningeal vessels engorged**, purulent exudate.
* **neutrophils in subarachnoid** space. may have cerebritis.
* **phlebitis ⇒ venous thrombosis and hemorrhagic infarction**.
* resolution ⇒ **leptomeningeal fibrosis and hydrocephalus**
* _presentation_: **fever, headache**, **photophobia**, **irritability, clouded sensorium**, **neck stiffness**.
* **CSF** purulent with neutrophils and organisms, **↑ protein, and ↓ glucose.**
60
**Acute Viral Meningitis**
* **meningeal irritation, CSF lymphocytic pleocytosis, mod ↑ protein, normal glucose**.
* self-limited.
61
**Brain Abscess**
* **destructive lesion coming from bacterial endocarditis, congenital heart disease, chronic pulmonary sepsis, or immunosuppression**.
* mainly **strep and staph**.
* _morphology_: **central region of liquefactive necrosis**. older have **fibrous capsule with reactive gliosis and marked vasogenic edema.**
* _presentation_: **progressive focal neurologic deficits and signs of ↑ ICP**.
* subdural space infected ⇒ **thrombophlebitis** ⇒ venous occlusion and brain infarction.
62
**Tuberculous Meningitis**
* can ⇒ **arachnoid fibrosis, hydrocephalus, obliterative endarteritis**
* _morphology_: **diffuse meningoencephalitis**. subarachnoid has **gelatinous or fibrinous exudate** of chronic inflammatory cells. granulomas at base of brain are rare ⇒ **obliterate cisternae and encase cranial nerves**.
* **arteries in subarachnoid may have obliterative endarteritis**.
* _presentation_: **headache, malaise, mental confusion, vomiting**.
* **mod CSF mononuclear cell pleocytosis, ↑ protein, mod ↓ or normal glucose**.
63
**Neurosyphilis**
* tertiary stage of disease, 10%.
* ↑ risk in HIV pts.
* **_meningovascular neurosyphilis_** = **chronic meningitis** associated with **obliterative endarteritis**.
* **_paretic neurosyphilis_** = from brian **invasion by spirochetes with neuronal loss and microglial proliferation**
* have **insidious loss of mental and physical capacity with mood alterations ⇒ severe dementia.**
* **_tabes dorsalis_** = from **spirochete damage to dorsal root sensory neurons** ⇒ **impaired joint position sense, locomotor ataxia, loss of pain with secondary skin and joint damage (Charcot joints), absent deep tendon reflexes.**
64
**Neuroborreliosis**
* in **Lyme disease**.
* includes **septic meningitis, facial nerve palsies, encephalopathy**.
* microglial proliferation and scattered organisms.
65
**Arthropod-Borne Viral Encephalitis**
* inflammed meninges or spinal cord.
* from Eastern and Wester Equine viruses, Venezuelan virus, St. Lous virus, La Crosse virus, West Nile virus.
* all have animal hosts and mosquito or tick vector.
* _presentation_: **seizures, confusion, delirium, stupor or coma**.
66
**Hereps Simplex Virus Type I**
* inflammed meninges or spinal cord.
* most common in kids or young adults.
* _morphology_: **hemorhagic, nectrotizing encephalitis of inferomedial temporal lobes and orbital gyri of frontal lobes**.
* perivascular infiltrates with **Cowdry A intranuclear viral inclusion bodies** in neurons and glia.
* _presentation_: **alterations in affect, mood, memory, and behavior**.
* protracted course = **weakness, lethargy, ataxia, and seizures**.
67
**Herpes Simplex Virus Type II**
* **severe generalized encephalitis in 50% neonates** born vaginally.
* ⇒ **meningitis in adults**, severe hemorrhagic, necrotizing **encephalitis in HIV pts.**
68
**Varicella Zoster (Brain)**
* shingles can cause **persistent painful post-herpetic neuralgia syndrome**.
* **granulomatous arteritis, or necrotizing encephalitis** in immunocompromised
69
**Cytomegalovirus (Brain)**
* in **utero** infection ⇒ **periventricular necrosis, microcephaly, and periventricular calcification**.
* in AIDS = opportunistic infection ⇒ **subacute encephalitis with microglial nodules or periventricular hemorrhagic necrotizing encephalitis and choroid plexus**.
* has classic **CMV inclusions**.
70
**Poliomyelitis**
* **inflammation confined to anterior horns** but can extend to posterior horns.
* meningial irritation and CSF picture of aseptic meningitis.
* involves **lower motor neurons ⇒ flaccid paralysis with hyporeflexia** and 2° muscle wasting.
* can get **myocarditis**, death from respiratory muscle paralysis.
* _presentation_: **_post-polio syndrome_** = **25-35yrs after polio, progressive weakness associated with pain and ↓ muscle mass**.
71
**Rabies (Brain)**
* **severe encephalitis from rabid animal** or exposure to a bat without a bite.
* over 1-3 months the virus travels up peripheral nerves ⇒ **CNS excitability, hydrophobia, flaccid paralysis**.
* death from respiratory center failure.
* widespread **neuronal necrosis and inflammation**.
* worst in basal ganglia, midbrain, medulla.
* **Negri bodies** in hippocampal pyramidal cells and Purkinje cells.
72
**HIV (Brain)**
* **10% get aseptic meningitis within 1-2 wks of primary HIV infection**.
* HIV encephalitis in symptomatic pts.
* only **microglia express CD4 and chemokine receptors for efficient HIV infection**.
* **80-90% get CNS lesions**: direct viral pathogenic effects, opportunistic infections, and/or CNS lymphomas.
* **_HIV-associated dementia_** = related to extent of activated CNS microglia.
* _morphology_: chronic inflammatory reaction with **widely distributed microglial nodules, multinucleated giant cells**, with **necrosis and gliosis**.
* most affects **subcortical white matter, diencephalon, brain stem.**
73
**Progressive Multifocal Leukoencephalopathy**
* from **oligodendrocyte infection by JC polyomavirus** in immunosuppressed pts.
* have evidence of prior JC exposure so is reexposure.
* develop progressive **neuro manifestations from focal myelin destruction**.
* _morphology_: **demyelinated patches**, greatly **enlarged oligodendrocyte nuclei** with **viral inclusions**. **astrocytes with enlarged atypical nuclei**.
74
**Subacute Sclerosing Panencephalitis**
* SSPE. **progressive syndrome of cognitive decline, limb spasticity, and seizures**.
* occurs months to years **after early age measles infection. **
* presistent but nonproductive CNS infection.
* **widespread gliosis and myelin degeneration**, associated with **nuclear inclusions in oligodendrocytes** and neurons.
* variable inflammation with **neurofibrillary tangles.**
75
**Fungal Meningoencephalitis**
* in **immunocompromised patients with widespread hematogenous dissemination**
* Candida, Mucor, Aspergillus, Cryptococcus.
* Histoplasma, Coccidioides, and Blastomyces involve CNS after pulmonary or cutaneous infections.
* **_meningitis_**: by **Cryptococcus**.
* fulminant and fata within 2 wks or chronic and indolent over months-yrs.
* **_vasculitis_**: **Mucor and Aspergillus**.
* vessel invasion with thrombosis and hemorrhagic infarction.
* **_granulomas or abscesses_** with **Candida and Cryptococcus**.
76
**Toxoplasma gondii (Brain)**
* seen in **HIV pts**.
* symptoms **over 1-2 wks**, are **focal**.
* multiple **ring-enhanced lesions**.
* **abscesses with fre tachyzoites and encysted bradyzoites**.
* maternal infection can ⇒ **fetal cerebritis with multifocal necrotizing lesions that calcify.**
77
**Naegleria (Brain)**
* causes **rapidly fata necrotizing encephalitis**.
78
**Acanthamoeba**
* associated with **chronic granulomatous meningoencephalitis**
79
**Prion Diseases**
* have **spongiform changes** (neuronal and glial intracellular vacuoles) caused by **prion proteins**. (PrP).
* infectious, sporadic, or familial.
* **Creutzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia, and kuru**.
* _pathogenesis_: disease when becomes **abnormally folded as beta-pleated sheet**.
* can induce changes in normal PrP.
* polymorphisms at **codon 129 (for methionine or valine)** influence disease.
* heterozygosity at codon 129 is protective.
80
**Creutzfeldt-Jakob Disease**
* **85% sporadic**. peaks btw **60-70yrs**.
* _presentation_: **subtle memory and behavior changes**, then **rapidly progressive dementia, with involuntary jerking muscle contractions**.
* **fatal**. die ~7months after symptom onset.
81
**Variant Creutzfeldt-Jakob Disease**
* in **young adults**.
* **early behavior manifestations and slower neurologic progression**.
* linked to **bovine spongiform encephalopathy**.
* **extensive cortical plaques** with surrounding **halo of spongiform change**.
82
**Gerstmann-Strauss-Scheinker Syndrome**
* **inherited disease with PRNP mutations**.
* _morphology_: **spongiform transformation of cerebral cortex and deep gray matter structures** (caudate and putamen).
* advanced = s**evere neuronal loss, reactive gliosis**, expansion of vacuolated areas into cystlike spaces (**status spongiosus**).
* kuru plaques = extracellular aggregates of PrPsc proteins on congo-red and PAS-pos.
* _presentation_: **chronic cerebellar ataxia, then progressive dementia**.
* death a few years after symptom onset.
83
**Fatal Familial Insomnia**
* **PRNP mutations** substitute **aspartate for asparagine at 178** of PrPc.
* **mutation and methionine at 129 ⇒ FFI**.
* valine at 129 ⇒ CJD.
* _morphology_: NO spongiform changes. ** neuronal loss and reactive gliosis in inferior olivary nuclei and anterior ventral and dorsomedial nuclei of thalamus**.
* _presentation_: **sleep disturbances** in initial stages.
84
**Multiple Sclerosis**
* autoimmune demyelinating disorder with **distinct episodes of neurologic deficit separated in time** and attributable to **white matter lesions** that are separated in space.
* **F\>M**. peak age btw **childhood and 50yrs.**
* **relapsing and remitting** with acute deficit onset and slow partial remission.
* relapse frequency increases over time but have **steady neuro deterioration**.
* _pathogenesis_: cellular immune response against myelin.
* susceptibility linked to **DR2 locus** of major histocompatibility complex and **polymorphisms in IL-2 and IL-4 receptor genes**.
* initiated by **TH1 and TH17 cells ⇒ myelin destruction**.
* TH1 ⇒IFNgamma ⇒ activate macrophages
* TH17 ⇒ recruit leukocytes.
* **CSF has oligoclonal Ig response** = B cell response.
* _morphology_: plaques are **sharply defined areas of gray discoloration of white matter around ventricles**.
* **_active plaques_** have **myelin breakdown, lipid-laden macrophages, and relative axonal preservation**.
* **lymphocytes and mononuclear cells at plaque edges and venules**.
* **_inactive plaques_** lack inflammatory infiltrate, show **gliosis**.
* axons remain but are unmyelinated.
* _presentation_: **unilateral vision impairment** from optic neuritis.
* **cranial nerve signs, ataxia, nystagmus, internuclear ophthalmoplegia** from brainstem involvement.
* **limb and trunk motor and sensory impairment, spasticity, and bladder dysfunction** from spinal cord lesions.
85
**Neuromyelitis Optica**
* aka **Devic disease**.
* **bilateral optic neuritis and spinal cord demyelinating lesions**.
* white matter lesions = **necrosis with acute inflammation, vascular Ig and complement deposits**.
* **Ab to aquaporins** - important for astrocyte foot processes and BBB.
86
**Acute Disseminated Encephalomyelitis**
* **diffuse demyelinating disese after viral infection**.
* **perivenular demyelination with axonal preservation**, early neutrophil infiltrates then mononuclear cell inflammation and **lipid-laden macrophages**.
* _presentation_: **headache, lethargy, and coma**. no focal deficits. **20% die**.
87
**Acute Necrotizing Hemorrhagic Encephalomyelitis**
* **fulminant**, commonly fatal, **demyelinating syndrome in kids and young adults after upper respiratory tract infection**.
* **small vessel destruction and disseminated CNS necrosis**.
* have perivascular demyelination with axonal preservation. early neutrophils then mononuclar cells then lipid-laden macrophages.
88
**Central Pontine Myelinosis**
* **myelin damage with axonal preservation** but without inflammation in **basis pontis and portions of pontine tegmentum** ⇒ **spastic paresis**.
* associated with **rapid correction of hypnatremic state**.
89
**Alzheimer Disease**
* begins **after age 50yr**. progressive **insidious impairment of higher intellectual function over 5-10yrs**.
* mostly **sporadic**.
* common cause of death = **intercurrent disease** (pneumonia)
* _morphology_: **cortical atrophy with narrowed gyri and widelned sulci** in **frontal, temporal, and parietal lobes**. ** hydrocephalus ex vacuo**, medial temporal structures involved early.
* **neuritic plaques and neurofibrillary tangles**.
* **cerebral amyloid angiopathy** (CAA) = alpha-beta amyloid deposition
* **granulovacuolar degeneration** = formation of small clear intraneuronal cytoplasmic vacuoles.
* **Hirano bodies** = elongated, glassy eosinophilic paracrystalline arrays of beaded filaments, mostly actin.
* _pathogenesis_: **AB deposition** can be neurotoxic ⇒ **synaptic dysfunction, inflammation**
* familial forms = **mutation in APP** on chromosome 21
* **Down syndrome** have early onset.
* early onset from **mutations in presenilin (PS1 or PS2) **⇒ enhanced gamma-secretase activity.
* **apolipoprotein epsilon4** ⇒ ↑ risk
90
**Frontotemporal Dementia with Parkinsonism Linked to Tau Mutations**
* have **parkinsonian** symptoms
* **mutation in MAPT (tau) gene**, affects tau in **microtubules**.
* _morphology_: **frontal and temporal lobe atrophy.**
* **neuronal loss, gliosis**, tau-containing **neurofibrillary tangles.**
* can have **nigral degeneration or glial cell inclusions**.
91
**Pick Disease**
* causes **dementia**.
* prominent **frontal signs**.
* _morphology_: **frontal and temporal lobe atrophy**. **spares posterior 2/3 of superior temporal gyrus**. caudate and putamen can atrophy.
* large ballooned neurons (**Pick cells**) and smooth agyrophilic inclusions made of straight and paired helical filaments (**Pick bodies**)
92
**Progressive Supranuclear Palsy**
* **men \> 50yrs**
* from gene polymorphisms, **MAPT haplotype**
* _morphology_: **widespread neuronal loss and neurofibrillary tangles** in globus pallidus, subthalamic nucleus, substantia nigra, colliculi, periaqueductal gray matter, dentate nucleus.
* **tau** pathology **in glial cells**
* _presentation_: **loss of vertical gaze, truncal rigidity, dysequilibrium, loss of facial expression, mild progressive dementia**.
* death within 5-7 yrs
93
**Corticobasal Degeneration**
* disease of elderly
* same **MAPT haplotype** as progressive supranuclear palsy
* _morphology_: motor, **premotor, and anterior parietal cortex** have **neuronal loss, gliosis, ballooned neurons**.
* **loss of pigmented neurons and argyrophilic inclusions** in substantia nigra and locus ceruleus.
* **tufted astrocytes** = tau immunoreactivity
* **coiled bodies** = tau immunoreactivity in oligodendrocytes
* _presentation_: **extrapyramidal rigidity, asymmetric motor disturbances, sensory cortical dysfunction**
94
**Vascular Dementia**
* vascular injury ⇒ **↓ threshold for dementing effects of other disorders**.
* from **multiple lacunar infarcts, HTN disease** (Binswanger disease), **specially located large infarcts** (hippocampus, dorsomedial thalamus, frontal cortex), **vasculitis**.
95
**Parkinsonism**
* _causes_: **Parkinson disease, multiple system atrophy, postemcephalitic parkinsonism** (1918 flu pandemic), **frontotemporal dementias, dopamine antagonists or toxins.**
* _presentation_: **diminished facial expression, stooped posture, slow voluntary movement, festinating gait** (shortened and accelerated), **rigidity, pill-rolling tremor** (↓ function of nigrostriatal dopaminergic system)
96
**Parkinson Disease**
* progressive L-DOPA responsive parkinsonism without toxic etiology.
* _morphology_: **pallor of substantia nigra and locus ceruleus with loss of pigmented catecholaminergic neurons and gliosis**
* remaining neurons have lewy bodies = intracytoplasmic eosinophilic inclusions with alpha-synuclein.
* _pathogenesis_: **_autosomal dominant_** forms = overexpression of **alpha-synuclein** or gain of function in **LRRK2** gene
* **_juveninle recessive_** form = loss of function in **parkin gene**
* **_recessive forms_** = mutated **DJ-1 and PINK1 kinase**
* **lose dopaminergic neurons in substantia nigra** from **alpha-synuclein aggregation, proteasome dysfunction, altered mitochondrial activity.**
* leads to **striatal dopamine deficiency**.
* _presentation_: **autonomic and cognitive dysfunction with diminished facial expression, stooped posture, slowed voluntary movement, festinated gait, rigidity, pill-rolling tremor.**
* L-DOPA improves it but become refractory.
* _tx_: **L-DOPA**, neural transplantation, gene therapy, neurosurgical lesions in extrapyramidal system, **deep brain stimulation.**
97
**Dementia with Lewy Bodies**
* dementia in 10-15% PD patients.
* some have Alzheimers
* most have **alpha-synuclein-containing lewy bodies**
* flluctuating course with **hallucinations and frontal signs.**
98
**Multiple System Atrophy**
* **atrophy** in CNS regions with **glial tubular cytoplasmic inclusions** made of **alpha-synuclein, ubiquitin, and alpha-B crystallin**
* **_striatonigral degeneration_** = parkinsonism
* atrophy of substantia nigra and striatum.
* **_olivopontocerebellar atrophy_** = cerebellar ataxia, eye and somatic movement abnormalities, dysarthria, rigidity.
* atrophy of cerebellar peduncles, basis pontis, inferior olives.
* **_Shy-Drager syndrome_** = autonomic dysfunction with loss of sympathetic neurons of intermediolateral column in spinal cord.
99
**Striatonigral Degeneration**
* **parkinsonism**
* atrophy of **substantia nigra and striatum**.
100
**Olivopontocerebellar Atrophy**
* **cerebellar ataxia, eye and somatic movement abnormalities, dysarthria, rigidity.**
* atrophy of **cerebellar peduncles, basis pontis, inferior olives**.
101
**Shy-Drager Syndrome**
* **autonomic dysfunction** with loss of sympathetic neurons of **intermediolateral column in spinal cord**.
102
**Huntington Disease**
* **autosomal dominant** movement disorder.
* _morphology_: atrophy of **caudate nucleus and putamen**, **loss of med-sized spiny striatal neurons** that use GABA.
* **gliosis and intraneural huntingtin aggregates in striatum and cerebral cortex.**
* spares neurons with NO synthase and cholinesterase
* _pathogenesis_: **expansion of CAG repeat in huntingtin** (\>36 repeats) ⇒ toxic gain of function, aggregation, sequester transcriptional regulators, dysregulate transcription pathways for mitochondrial biogenesis or protection from oxidative injury.
* **anticipation** = parental transmission ⇒ earlier expression in kids.
* _presentation_: btw **ages 20-50yrs, get chorea** (jerky, hyperkinetic, dystonic movements)** ⇒ parkinsonism**
* motor symptoms precede cognitive impairment ⇒ **death in 15 yrs.**
103
**Friedreich Ataxia**
* **autosomal recessive**
* **expansion of intronic GAA** repeat in gene for **frataxin** (mitochondrial membrane protein for iron regulation).
* _morphology_: **axonal loss and gliosis posterior columns of spinal cord, distal corticospinal and spinocerebellar tracts.**
* **neuronal degredation** of **CN VIII, X, XII nuclei, dentate nucleus, Purkinje cells in superior vermis, and dorsal root ganglia.**
* _presentation_: **gait ataxia, hand clumsiness, dyarthria, depressed tendon reflexes, sensory loss.**
* wheelchair bound in 5 yrs.
* death from **cardiac arrhythmias or pulmonary infections**.
104
**Ataxia-Telangiectasia**
* **autosomal recessive**
* **mutated ATM** gene that repairs dsDNA breaks ⇒ ↑ risk malignancy and **neurons more degradation prone.**
* _morphology_: **cerebellar Purkinje and granule cells lost.**
* **degeneration of dorsal columns, spinocerebellar tracts, anterior horn cells**.
* **Schwann cell nuclei** in dorsal root ganglia and peripheral nerves are **2-5x enlarged.**
* _presentation_: **kids** have **cerebellar dysfunction, telangiectatic lesions in skin and conjunctiva, and immunodeficiency** (lymph nodes and thymus hypoplastic).
* death btw 10-20yrs old.
105
**Amyotrophic Lateral Sclerosis (ALS)**
* aka Motor Neuron Disease
* **loss of lower and upper motor neurons**.
* _pathogenesis_: **5-10% familial** and autosomal dominant.
* **25%** from gain of function in **SOD1 gene** for copper zinc superoxide dismutase ⇒ **misfolded proteins that cause unfolded protein response.**
* may have **abnormal axonal transport, protein accumulation, glutamate NT toxicity.**
* _morphology_: upper motor neuron degeneration ⇒ **demyelination in corticospinal tracts and reactive gliosis**. can be **atrophy of precentral gyrus.**
* remaining neurons have **Bunina bodies** = PAS-pos cytoplasmic inclusions.
* affected **skeletal muscles have neurogenic atrophy**.
* _presentation_: **m**\>f, **age\>40yrs**. **early clumsiness ⇒ muscle weakeness and fasciculations** that ⇒ **pneumonia** when respiratory muscles involved
* may have bulbar manifestations (involve motor CN) ⇒ **problems with deglutition and phonation.**
* progressive, **die from respiratory complications.**
106
**Bulbospinal Atrophy**
* aka **Kennedy syndrome**.
* **X-linked.**
* expansion of **CAG/polyglutamine trinucleotide repeat** in androgen receptor gene ⇒ **intranuclear receptor aggregation.**
* lower motor neuron loss ⇒ **androgen insensitivity** (gynecomastia, testicular atrophy, oligospermia).
107
**Neuronal Ceroid Lipofuscinoses**
* inherited lysosomal storage disorders ⇒ **neuronal accumulation of lipofuscin.**
* can ⇒ **blindness, mental and motor deterioration, and seizures**.
108
**Krabbe Disease**
* **autosomal recessive**
* **deficiency of galactocerebroside beta-galactosidase** ⇒ ↑ ceramide
* alternate pathway causes excess ⇒ **galactosylsphingosine**, toxic to oligodendrocytes.
* _morphology_: **diffuse loss of myelin and oligodendrocytes**
* aggregates of **Globoid cells** = glycolipid-engorged macrophages.
* _presentation_: **weakness and stiffness by age 3-6months**. die by age 2 yrs.
109
**Metachromatic Leukodystrophy**
* **autosomal recessive**
* **deficiency of arylsulfatase** ⇒ **accumulate cerebroside sulfate**. may **block oligodendrocyte differentiation**.
* _morphology_: **myelin loss, gliosis, macrophages containing metachromatic material**.
110
**Adrenoleukodystrophy**
* progressive disorder from **loss of myelin and adrenal insufficiency ⇒ inability to catabolize very long chain fatty acids**
111
**Pelizaeus-Merzbacher Disease**
* **X-linked**
* mutation in **gene encoding two alternatively-spliced myelin proteins** (ex. PLP and DM20)
112
**Mitochondrial Encephalopathy with Lactic Acidosis and Strokelike Episodes (MELAS)**
* most common neurologic syndrome with mitochondrial abnormalities.
* involves **mitochondrial tRNA**.
* _presentation_: **muscle and metabolic findings, recurrent neurologic dysfunction and cognitive changes.**
* **strokelike episodes have reversible deficits.**
113
**Leigh Syndrome**
* aka Subacute Necrotizing Encephalopathy
* **mutations in oxidative phosphorylation pathway**.
* _morphology_: **bilateral brain damage** with **vascular proliferation and spongiform changes**.
* **symmetrically** involves **midbrain periventricular gray matter, pontine tegmentum, thalamus, and hypothalamus.**
* _presentation_: **1-2yrs** old with **developmental arrest, feeding problems, seizures, extraocular palsies, hypotonia, and lactic acidemia**.
114
**Thiamine (Vitamin B1) Deficiency**
* ⇒ Beriberi, Wernicke encephalopathy, Korsakoff syndrome.
* **_Beriberi_** = **nutritional** deficiency. associated with **cardiac failure**
* **_Wernicke encephalopathy_** = **sudden onset psychosis and/or ophthalmoplegia**
* **_Korsakoff syndrome_** = progresses from Wernicke's to an **irreversible memory disorder with conflabulation**.
* common in **alcoholics**
* can come from **gastric disease**: carcinoma, chronic gastritis, persistent vomiting.
* _morphology_: **mammilary body** (and 3rd and 4th ventricle) **hemorrhage and necrosis**.
* **thalamic dorsomedial nucleus lesions** ⇒ memory disturbances.
115
**Vitamin B12 Deficiency**
* ⇒ **anemia and nervous system injury**.
* _morphology_: **vacuolar swelling of myelin** affects both ascending and descending tracts **starting at midthoracic cord.**
* _presentation_: slight **ataxia and lower extremity paresthesias** ⇒ **lower extremity spastic weakness and paraplegia**, may be permanent.
116
**Hypoglycemia**
* affects **large cerebral pyramidal cells, hippocampal pyramidal cells in CA1, and Purkinje cells**.
* prolonged, severe hypoglycemia ⇒ global neuronal injury.
117
**Hyperglycemia**
* from **poorly controlled DM**.
* can ⇒ **ketoacidosis**.
* hyperosmolar state has dehydration ⇒ **confusion, stupor, coma.**
* gradually correct fluid depletion to prevent cerebral edema.
118
**Carbon Monoxide (Brain)**
* causes **hypoxia** from **↓ oxygen carrying capacity of hemoglobin.**
* **injures neurons in layers III and V** in **cerebral cortex, hippocampal Sommer sector, and Purkinje cells**.
* ⇒ **bilateral necrosis of globus pallidus**.
119
**Methanol (Brain)**
* toxicity affects **retina**.
* **degeneration of ganglion cells ⇒ blindness**.
* may be from **formic acid** (metabolite of methanol)
120
**Radiation (Brain)**
* causes **acute CNS decompensation**, can develop **months to years later**.
* late radionecrosis associated with **large zones of coagulative necrosis and edema in white matter**.
* **blood vessels have thickened walls with intramural fibrin-like material**. **proteinaceous spheroids** in adjacent tissues.
* can be synergistic with methotrexate.
121
**Pilocytic Astrocytoma**
* **kids and young adults**.
* **benign** tumor in **cerebellum, floor and walls of 3rd ventricle, optic nerve, cerebral hemispheres**.
* usually a **p53 mutation**.
* _morphology_: **grade I/**IV tumor. **cystic with mural nodule in wall of cyst.**
* **bipolar cells with long, thin, hairlike processes**.
* **Rosenthal fibers** and **microcysts**.
* narrow infiltrative border surrounding brain.
122
**Inflitrating Astrocytomas**
* **80% of adult primary brain tumors**.
* age: **30-60 yr**.
* **_low grade_**: **overexpress PDGF-alpha** and receptor. **mutated p53** function.
* **_high grade_**: mutation of **RB, p16/CDKNaA ⇒ activate RAS and PI-3 kinase pathways, inactivate RB and p53**
* _morphology_: **grades II-IV**.
* _presentation_: **focal neurologic deficits, headaches, seizures**, from mass effects or cerebral edema.
* **high grade have contrast enhancement** on imaging.
123
**Diffuse Astrocytomas**
* infiltrating astrocytoma
* **grade II**/IV
* **poorly defined, gray-white**. **expands and distorts** a region of the brain.
* **hypercellularity** and **nuclear pleomorphism**
* **indistinct transition** from normal to neoplastic
124
**Anaplastic Astrocytoma**
* infiltrating astrocytoma
* **grade III**/IV.
* **↑ nuclear anaplasia** with **numerous mitoses**.
125
**Glioblastomas**
* infiltrating astrocytoma
* **grade IV**/IV.
* mixture of **firm white areas, soft yellow areas of necrosis, cystic change, and hemorrhage**.
* **↑ vascularity**
* **pseudopalisading** = ↑ tumor cell density along necrotic edges.
* poor prognosis, typically **survive about 15 months**.
126
**Pleomorphic Xanthoastrocytomas**
* **temporal lobes** of **young patients** with history of **seizures**.
* **grade II**/IV.
* **neoplastic bizarre astrocytes, abundant reticulin and lipid deposits, chronic inflammatory cell infiltrates**.
* 5 yr survival = 80%.
127
**Brainstem Gliomas**
* ages **0-20yrs**.
* **_pontine_** is most common, **aggressive**.
* **_tecta_** are benign.
* **_corticomedullary junction_** = intermediate.
128
**Oligodendroglioma**
* 5-15% of gliomas.
* in **mid life**.
* usually **loss of heterozygosity in chromosomes 1p and 19q**.
* _morphology_: in **white matter. well circumscribed, gelatinous, gray masses with cysts, focal hemorrhage, and calcification**.
* **sheets of regular cells with round nuclei** containing **finely granular chromatin surrounded by halo of cytoplasm**. sit in delicate capillary network.
* **calcification in 90**%.
* _presentation_: better prognosis than astrocytomas. **only have 1p 19q respond well to chemo and radiation**.
* survival **5-10 yrs**
* **anaplastic = grade III**/IV, worse prognosis.
129
**Ependymoma**
* tumor arising **from ependymal lining**.
* ages 0-20yrs: usually in **_4th ventricle_**.
* **_spinal cord central canal_** = middle age and neurofibromatosis type II.
* _morphology_: moderately **well-demarcated solid or papillary lesions.**
* **round-oval nuclei** with abundant **granular chromatin.**
* form **elongated ependymal canals or pervascular pseudorosettes**.
* **grade II**/IV.
* **anaplastic = grade III**/IV. have **↑ cell density, mitoses, necrosis with less evident ependymal differentiation.**
* _presentation_: **posterior fossa ependymomas have hydrocephalus**. **CSF dissemination** common.
* **50% 5 yr survival**.
* spinal cord lesions do better
130
**Myxopapillary Ependymoma**
* arises **in filum terminale** of spinal cord.
* **cuboidal cells**, can have clear cytoplasm, **around papillary core.**
* **myxoid areas have neutral and acidic mucopolysaccharides**
131
**Subependymoma**
* **solid, calcified, slow growing nodules** attached to **ventricular lining**, **protruding into ventricle**.
* usually **asymptomatic**, can cause **hydrocephalus**.
* _morphology_: **clumps of ependymal-appearing nuclei** scattered in **dense, finely fibrillar background**
132
**Choroid Plexus Papilloma**
* recapitulate normal choroid plexus.
* **CT papillae covered with cuboidal-columnar ciliated epithelium**.
* **hydrocephalus** from obstruction or CSF overproduction.
133
**Choroid Plexus Carcinoma**
* rare **adenocarcinoma**.
* usually in **kids**
134
**Colloid Cysts of 3rd Ventricle**
* **non-neoplastic lesion** in **young adult**.
* in **foramen of Monro**.
* ⇒**noncommunicating hydrocephalus**. can be fatal.
* contains **gelatinous, proteinaceous material** in a **thin fibrous capsule lined by cuboidal epithelium.**
135
**Ganglioglioma**
* **most common CNS tumor of mature-appearing neurons** (ganglion cells).
* **slow growing** even if aggressive.
* _morphology_: in **temporal lobe**, **cystic** component.
* **neoplastic ganglion cells irregularly clustered, randomly oriented neurites.**
* glial component **resembles low grade astrocytoma without necrosis/mitotic activity**.
* _presentation_: **seizures** that remit after resection.
136
**Dysembryoplastic Neuroepithelial Tumor**
* rare, **low grade childhood neoplasm**.
* _morphology_: **intracortical location, cystic changes, nodular growth, 'floating neurons'** in **mucopolysaccharide rich fluid, surrounding neoplastic glia** **without anapastic features**.
* _presentation_: **seizure** disorder.
* good prognosis with resection.
137
**Central Neurocytoma**
* **low grade neuronal neoplasm in ventricles**.
* **evenly spaced, round, uniform nuclei** and **islands of neuropil.**
138
**Medulloblastoma**
* **20% childhood brain tumors**.
* in **cerebellum**.
* **loss of material from 17p with isochromosome of 17q**.
* **MYC amplification** = more aggressive.
* **↑ neurotropin receptor TRKC or ↑ intranuclear beta-catenin** = better outcome.
* _morphology_: **well circumscribed, gray and friable**.
* extremely **cellular**, has **sheets of anaplastic cells with hyperchromatic nuclei and abundant mitoses.**
* **little cytoplasm, devoid of differentiation markers**. can have glial and neuronal features.
* **prominent desmoplasia** if extend into **subarachnoid space**.
* _presentation_: **midline lesion in kids, lateral in adults**.
* rapid growth ⇒ occlude CSF flow, **hydrocephalus**.
* **CSF dissemination**
* **highly malignant**, poor prognosis untreated.
* with excision and radiation have 75% 5 yr survival.
139
**Atypical Teratoid/Rhabdoid Tumor**
* highly **malignant** tumor in **posterior fossa and supratentorium** of **young kids**.
* **survive \<1yr**.
* **chromosome 22 deletions. hSNF5/INI1** that encodes protein in chromatin remodeling.
* **large, soft tumor over brain surface**.
* **highly mitotic** lesion with **rhabdoid cells** resembling rhabdomyosarcoma.
140
**Primary Central Nervous System Lymphoma**
* 2% of extranodal lymphomas, 1% intracranial tumors.
* most common CNS neoplasm **in immunocompromised**.
* **multifocal within CNS**. outside metastasis is late complication.
* **B-cell origin**, infected with **EBV**
* **aggressive**, respond poorly to chemo
* _morphology_: **diffuse large-cell B-cell lymphoma**.
* involve **parenchyma of brain**, see **around blood vessels.**
141
**Germ Cell Tumors**
* along **midline in adolescents and young adults**.
* 0.2-1% caucasian CNS tumors, **10% Japanese**
* in **pineal gland** (**men**) and **suprasellar regions**.
142
**Meningioma**
* **benign** tumor of **adult** coming **from arachnoid meningothelial cells**, are **attached to dura**.
* **loss of heterozygosity of long arm of chromosome 22. NF2 gene** (merlin protein).
* _morphology_: **rounded masses with well-defined dural bases** compress brain but can separate it.
* **firm, lack necrosis or extensive hemorrhage**.
* gritty from **calcified psammoma bodies**.
* patterns = synctytial, fibroblastic, transitional, psammomatous, secretory, and microcystic. **grade I**/IV.
* proliferative index predicts behavior.
* _presentation_: **solitary**, slow growing lesion. manifest from **CNS compression or vague non-localizing symptoms**.
* uncommon in kids.
* **3:2 f**:m. **express progesterone receptors, grow faster during pregnancy**.
143
**Anaplastic Meningioma**
* **grade III**/IV.
* **aggressive**, **resemble sarcomas.**
* **high mitotic rates**
144
**Papillary Meningioma**
* **pleomorphic cells** arranged **around fibrovascular cores.**
* **grade III**/IV
145
**Rhabdoid Meningioma**
* **sheets of cells with hyaline eosinophilic cytoplasms composed of intermediate filaments**.
* **grade III**/IV.
* high recurrence rate.
146
**Tumors Metastatic to Brain**
* **50% intracranial tumors**.
* primary sites: **lungs, breast, skin** (melanoma), **kidney, and GI tract**.
* can also come from meninges.
* _morphology_: **sharply demarcated**, at **gray-white junction**. surrounded by **edema**.
* **meningeal carcinomatosis** = tumor nodules studding brain surface, spinal cord, and nerve roots.
* see in **lung and breast carcinomas**.
147
**Subacute Cerebellar Degeneration**
* **most common paraneoplastic syndrome**.
* have **Purkinje cell loss, gliosis, and inflammatory infiltrates**.
148
**Paraneoplastic Syndromes**
* from malignancy elsewhere.
* due to **anti-tumor immune responses cross reacting with CNS and PNS antigens**.
* subacute cerebellar degeneration, limbic encephalitis, eye movement disorders, subacute sensory neuropathy, Lambert-Eaton myasthenic syndrome.
149
**Limbic Encephalitis**
* paraneoplastic syndrome.
* **subacute dementia associated with perivascular inflammation, microglial nodules, neuronal loss, and gliosis**.
* **anterior and medial temporal lobes**.
150
**Eye Movement Disorders**
* paraneoplastic syndrome.
* associated with **childhood neuroblastomas**.
151
**Subacute Sensory Neuropathy**
* paraneoplastic syndrome.
* can be with limbic encephalitis.
* marked by **dorsal root ganglia inflammation and neuronal loss**.
152
**Schwannoma**
* **benign** tumor of **schwann cells**.
* associated with **vestibular branch of CN VIII at cerebellopontine angle** (vestibular schwannoma or acoustic neuroma).
* have tinnitus and hearing loss.
* **_extradural_** = associated with large nerve trunks.
* inactivating **mutation of NF2 ⇒ loss of merlin ⇒ hyperproliferation**
* _morphology_: **well-circumscribed encapsulated firm gray masses with cystic and xanthomatous changes.**
* **attached to nerve but separable**.
* **spinal tumors from dorsal roots**, extend through **vertebral foramen** = **dumbbell shape**.
* **Antoni A** = elongated cells with cytoplasmic processes, arranged in fascicles in areas of mod-high cellularity with little stromal matrix.
* **Antoni B** = less densely cellular tissues with microcysts and myxoid changes.
* **basement membrane deposition encasing single cells and collagen fibers**.
153
**Neurofibroma**
* discrete localized mass.
* **skin lesions** = nodules. can be **large and pedunculated.**
* **_plexiform neurofibromas_** = infiltrating lesion that **expands peripheral nerve**.
* loss of both **NF1 genes** ⇒ **↓ RAS GTPase, ↑ RAS function**
* **can't separate from nerve**.
* **loose myxoid background, low cellularity**.
* **_NF1_** = multiple or plexiform lesions
* diffucult to remove from nerve, **↑ risk malignancy.**
154
**Malignant Peripheral Nerve Sheath Tumors**
* highly **malignant**, **locally invasive sarcomas**.
* **de novo** or from **plexiform neurofibroma transformation** (NF1).
* **ill-defined mass infiltrating parent nerve and adjacent soft tissue.**
* **resembles schwann cells**. **fascicle formation, mitosis, necrosis, anaplasia.**
155
**Cowden Syndrome**
* **dysplastic cerebellar gangliocytoma**s
* due to **PTEN mutation**.
156
**Li-Fraumeni Syndrome**
* **medulloblastoma** from **p53 mutation**
157
**Turcot Syndrome**
* **medulloblastoma** or **glioblastoma**
* **APC or mismatch repair gene mutation**
158
**Gorlin Syndrome**
* **medulloblastoma** from **PTCH mutation**
159
**Neurofibromatosis Type 1**
* **autosomal dominant**.
* **neurofibromas** (cutaneous and plexiform), **optic nerve gliomas, meningiomas**, pigmented nodules of iris (**Lisch nodules**), and cutaneous hyperpigmented macules (**café au lait spots**)
* can be disfiguring, create spinal deformities.
* **lack neurofibromin from biallelic gene inactivation (NF1).**
160
**Neurofibromatosis Type 2**
* **autosomal dominant**.
* **inactivation of NF2.**
* form **bilateral CN VIII schwannomas or multiple meningiomas**.
161
**Tuberous Sclerosis Complex**
* **autosomal dominant**
* **angiofibromas, seizures, mental retardation**.
* hamartomas include **cortical tubers** = haphazardly arranged neurons and cells expressing phenotypes intermediate btw glia and neurons; **subendymal hamartomas** = large astrocytic and neuronal clusters forming subependymal giant cell astrocytomas
* can have renal angiomyolipomas, retinal glial hamartomas, cardiac rhabdomyomas, pulmonary lymphangioleiomyomatosis
* cutaneous lesions = **angiofibromas, shagreen patches** (leathery thickenings), **sunungual fibromas**, hypopigmented areas (**ash-leaf patches**)
* **TSC1** encodes **hamartin**.
* **TSC2** encodes **tuberin**
* TSC1 and TSC2 form **complex that inhibits mTOR kinase ⇒ ↑ mTOR activity ⇒ ↑ protein synthesis and ↑ cell size.**
162
**Von Hippel-Lindau Disease**
* **autosomal dominant**
* causes **hemangioblastomas in cerebellum, retina, or brainstem and spinal cord**. **cysts in pancreas, liver, and kidney.**
* propensity for **renal cell carcinoma** and **pheochromocytomas**.
* **mutated VHL ⇒ dysregulated HIF-1 ⇒ ↑ expression VEGF, erythropoietin**, other growth factors.
* VHL encodes part of ubiquitin-ligase complex that downregulates HIF-1.
163
**Epineurium**
* encases all fascicles of entire nerve
164
**Perineurium**
* encases each fascicle
165
**Endoneurium**
* surrounds individual nerve fibers.
166
**Anterior Spinal Root**
* has motor fibers
167
**Posterior Spinal Root**
* has sensory fibers
168
**Type 1 Muscle Fiber**
* mneumonic: 'one slow fat red ox'
* ONE: **type 1**
* **SLOW**: twitch, sustained force, weight bearing.
* FAT: **lipid-rich**.
* RED: color is **red**.
* OX: oxidative, **many mitochondria**.
* ex. soleus
169
**Type 2 Muscle Fiber**
* for **sudden, purposeful movements**
* **type 2** fiber
* **fast**-twitch
* few lipids, **abundant glycogen**
* **white** color
* anaerobic: **few mitochondria, narrow Z-band**.
* ex: pectoral
170
**Segmental Demyelination**
* from **schwann cell dysfunction** or **myelin sheath damage**. axon is normal.
* denuded axons stimulate remyelination, **precursor cells in endoneurium replace injured schwann cells**.
* **internode distances shorter, myelin sheath thinner**.
* **onion bulbs** = recurrent demyelination and remyelination causes layers of Schwann cell processes.
* chronic demyelinating disorders ⇒ axonal injury.
171
**Wallerian Degeneration**
* **rxn distal to a transected axon**.
* reflects **axonal and myelin breakdown with macrophage recruitment and phagocytosis**.
* **proximal uninjured nerve** may have **focal degeneration of distal 2-3 internodes** before regenerative activity.
172
**Denervation Atrophy**
* in **muscle fibers of affected motor unit**.
* myocytes **smaller and more angular** but still **viable**.
173
**Nerve Regeneration**
* **proximal stump regrows 1mm/day**.
* guided by Schwann cells.
174
**Reinervation of Muscle**
* neighboring motor units **extend sprouts and incorporate muscle fibers into healthy motor unit.**
* get fiber type of the new innervating neuron ⇒ **type grouping**.
* injury of nerve innervating the type grouping patch ⇒ **group atrophy**.
* type 2 fiber atrophy = **disuse atrophy**
* see in **corticosteroid myopathy**
175
**Segmental Necrosis of Muscle Fiber**
* myofiber damage followed by **myophagocytosis** from infiltrating macrophages.
* fibers replaced with **collagen and fat**.
176
**Regeneration of Muscle Fiber**
* **satellite cells proliferate** to reconstitute fibers.
* new fibers have **large internalized nuclei, prominent nucleoli, basophilic cytoplasm laden with RNA**.
177
**Hypertrophy of Muscle Fibers**
* ↑ load ⇒ **enlarged fibers**
* **muscle fiber splitting** = divide longitudinally
* **one large fiber with central membrane**, have adjacent nuclei.
178
**Guillain-Barré Syndrome**
* aka acute inflammatory demyelinating polyradiculoneuropathy
* **acute life-threatening ascending paralysis**.
* _pathogenesis_: **immune-mediated**. 60-70% **preceded by vaccination or viral/bacterial infection**.
* viral = **EBV, CMV**
* bacterial = **Campylobacter, Mycoplasma**
* T cells or circulating Ab ⇒ **demyelination**.
* _morphology_: **segmental demyelination** with **chronic inflammation involving nerve roots and peripheral nerves.**
* severe = axonal damage.
* _presentation_: **muscle weakness, loss of deep tendon reflexes**.
* **begins in distal limbs**, rapidly includes **proximal**.
* **nerve conduction velocity slowed**.
* **CSF protein ↑**. no pleocytosis.
* **death** in 2-5% from **respiratory paralysis, autonomic instability, or cardiac arrest**.
* **20% permanent disability**.
179
**Chronic Inflammatory Demyelinating Polyradiculoneuropathy**
* mixed **sensorimotor neuropathy** similar to Guillain-Barré.
* has **relapses and remissions**.
* have **onion bulbs**.
180
**Leprosy**
* aka Hansen's Disease.
* by **M. leprae** **invading Schwann cells**. then proliferate and infect other cells.
* causes **segmental demyelination and remyelination, axonal loss, endoneurial and epineurial fibrosis**.
* **_lepromatous_**: disease more **severe and diffuse**. **symmetric polyneuropathy** in extremities.
* predilection for pain fibers ⇒ **don't feel pain, get large ulcers.**
* **_tuberculous_**: nodules of granulomatous inflammation, **localized nerve injury**.
181
**Diphtheria Neuropathy**
* from **diphtheria exotoxin**
* **segmental demyelination**
* _presentation_: **paresthesias and weakness**
182
**Varicella-Zoster Virus Neuropathy**
* **latent infection of spinal cord and brain stem sensory ganglia**.
* reactivation ⇒ **shingles**. trigeminal or thoracic nerve distribution.
* neuronal destruction with associated **mononuclear cell infiltrates**. peripheral nerves have **axonal degeneration.**
183
**Hereditary and Sensory Autonomic Neuropathies**
* HSANs. 5 types.
* _presentation_: **numbness, pain, autonomic dysfunction**.
184
**HSAN Type I**
* **autosomal dominant.**
* mutated **SPTLC-1** gene.
* _presentation_: **young adults**. **sensory neuropathy**. axonal degeneration of **myelinated fibers**.
185
**HSAN Type II**
* **autosomal recessive**.
* mutated **HSN2** gene.
* _presentation_: in **childhood**. **sensory neuropathy**. axonal degeneration of **myelinated fibers**.
186
**HSAN Type III**
* aka Riley-Day syndrome, familial dysautonomia.
* **autosomal recessive**.
* mutated **IKAP** gene.
* _presentation_: **Jewish kids**. **autonomic neuropathy**. **axonal degeneration of unmyelinated fibers**, atrophy and **loss of sensory and autonomic ganglion cells.**
187
**HSAN Type IV**
* **autosomal recessive** dysautonomia type II
* mutated **NTRK1** gene.
* _presentation_: **infants**. **insensitivity to pain and anhidrosis**. almost complete **loss of small myelinated and unmyelinated fibers**.
188
**HSAN Type V**
* **autosomal recessive**
* mutated **NGFB** gene.
* _presentation_: **infants**. **insensitivity to pain and temperature**. nearly complete **loss of small myelinated fibers.**
189
**Familial Amyloid Polyneuropathies**
* **autosomal dominant**.
* deposition of **amyloid in PNS**.
* mutated **transthyretin** (transports thyroxine and retinol).
* amyloid fibrils **made of transthyretin**.
* _morphology_: amyloid **deposits in vessel walls and CT with axonal degeneration**.
* _presentation_: **numbness, pain, autonomic dysfunction**.
190
**Adrenoleukodystrophy**
* **X-linked**. 4% female carriers symptomatic.
* mutated **ABCD1**.
* _morphology_: **segmental demyelination, onion bulbs, axonal degeneration** (myelinated and unmyelinated).
* **linear inclusions in Schwann cells**.
* _presentation_: mixed **motor and sensory neuropathy**, **adrenal insufficiency, spastic paraplegia.**
* onset btw **10-20 yrs in men** with leukodystrophy, **20-40 yrs in women** with myeloneuropathy
191
**Porphyria (AIP or Variegate Coproporphyria)**
* **autosomal dominant**
* mutated enzymes in heme synthesis
* AIP = **porphobilinogen**
* _morphology_: **acute and chronic axonal degeneration**, regenerating **clusters**.
* _presentation_: **acute episodes neuro dysfunction, psychiatric disturbances, abd pain, seizures, proximal weakness, autonomic dysfunction**.
* may be precipitated from drugs.
192
**Refsum Disease**
* **autosomal recessive**.
* mutated **PAHX** gene.
* _morphology_: severe **onion bulb** formation.
* _presentation_: **mixed motor and sensory neuropathy with palpable nerves, ataxia, night blindness, retinitis pigmentosa, ichthyosis**.
* onset **before age 20**.
193
**Charcot-Marie-Tooth Disease**
* aka hereditary motor and sensory neuropathy **(HMSN) type I**.
* **autosomal dominant** demyelinating disorder.
* _pathogenesis_: **HMSN-1A** has duplicated segment on chrom 17 ⇒ **↑ PMP-22** that compacts myelin as Schwann cells wrap around axons.
* **HMSN-1B** = mutated **MPZ.**
* mutations in connexin 32, protein degradation pathway, and myelination induction genes.
* _morphology_: **segmental demyelination** and **onion bulb.**
* _presentation_: **young adults** with **distal muscle weakness and calf atrophy.**
194
**HMSN II**
* **autosomal dominant**
* **axonal loss without demyelination**
* presents younger than HMSN type I.
* mutated **kinesin**.
195
**Déjérine-Sottas Neuropathy**
* aka HMSN III.
* **autosomal recessive. infantile.**
* progressive **upper and lower extremity weakness and muscle atrophy**, **enlarged palpable nerves**.
* mutated **PMP-22** or **MPZ**.
* **severe segmental demyelination, onion bulbs, axonal loss.**
196
**Peripheral Neuropathy in Adult-Onset DM**
* present in about 50% DM.
* from **nonenzymatic protein glycation and polyol-mediated damage**.
* **diabetic microvascular disease** with secondary ischemic injury.
* types: **distal symmetric sensory or sensorimotor neuropathy, autonomic neuropathy, focal or multifocal asymmetric neuropathy**.
197
**Distal Symmetric Sensory or Sensorimotor Neuropathy**
* **axonal neuropathy with loss of small fibers**.
* **sensory loss** \> motor loss.
* **loss of pain ⇒ cutaneous ulcers**, **heal poorly** from diabetic microvascular disease.
198
**Autonomic Neuropathy**
* 20-40% diabetics.
* _presentation_: **postural hypotension, incomplete bladder emptying, sexual dysfunction.**
199
**Focal or Multifocal Asymmetric Neuropathy**
* ex. unilateral ocular nerve palsy.
* **secondary to vascular insufficiency of peripheral nerves**.
200
**Metabolic and Nutritional Peripheral Neuropathies**
* from **renal failure**
* presents with distal symmetric sensory and motor neuropathy.
* from **chronic liver disease, respiratory insufficiency, thyroid dysfunction**.
* from **deficiencies of thiamine, B6, B12, or E**.
* from **excessive alcohol** consumption by ethanol toxicity and thiamine deficiency.
201
**Direct Infiltration or Nerve Compression**
* by tumor ⇒ **mononeuropathy, brachial plexopathy, cranial nerve palsy, or polyradiculopathy of lower extremities** (meningeal carcinomatosis of cauda equina)
202
**Paraneoplastic Syndrome of PNS**
* progressive **sensorimotor neuropathy** (lower extremities) in 2-5% **lung cancer**.
* **loss of dorsal root ganglia ⇒ sensory neuropathy**
* **circulating Ab against RNA-binding protein** shared by neurons and tumor cells.
* **deposition of light-chain amyloid** in pts with **plasma cell dyscrasias**
* secondary to **autoantibodies against myelin-associated glycoprotein**
203
**Toxic Neuropathies**
* from exposure to **industrial/environmental chemicals, biologic toxins, heavy metals** (lead, arsenic), **therapeutic drugs**.
204
**Traumatic Neuropathies**
* **lacerations** cutting a nerve
* **avulsions** when nerve under pressure
* **traumatic neuromas** from nerve transection or damage. **painful nodules of tangled axons and CT from regenerating axonal sprouts**.
* **compression neuropathy** = nerve compressed.
* **_Carpal Tunnel Syndrome_**: **median nerve entrapped in wrist**. see in edema, pregnancy, degenerative joint disease, hypothyroidism, amyloidosis, excessive wrist use.
* other nerves: **ulnar nerve at elbow, peroneal nerve at knee, radial nerve in upper arm**.
* **compression neuropathy of foot in women**.
* **_Morton neuroma_**: **involves interdigital nerve at intermetatarsal sites **⇒ pain
205
**Spinal Muscular Atrophy**
* **autosomal recessive** motor neuron diseases, **onset in childhood or adolescence.**
* mutations of **SMN1** gene on chromosome 5
* **# copies homologous SMN2 gene modifies gene severity**.
* SMN for axonal transport, NMJ integrity.
* loss ⇒ neuronal cell death.
* _morphology_: large numbers of **extremely atrophic muscle fibers**, involve entire fascicle of muscle
* _presentation_: **_SMA type I_** = Werdnig-Hoffman disease: presents **first 4 months of life with hypotonia and death by age 3 yr**.
* **_SMA type 2_**: presents later, **die as kid after age 4.**
* **_SMA type 3_**: survive to **adulthood**.
206
**Duchenne Muscular Dystrophy**
* **most severe and most common form** muscular dystrophy.
* **X-linked**. 1/3500 males.
* **DMD gene at Xp21** encodes dystrophin that transduces contractile forces from intracellular sarcomeres to ECM.
* 2/3 familial. 1/3 de novo
* **no detectable dystrophin**
* _morphology_: **enlarged, rounded, hyaline fibers lacking normal cross striations**.
* **variation in myofiber diameter, ↑ internalized nuclei, degeneration/necrosis/phagocytosis of muscle fibers, regeneration of muscle fibers, proliferation of endomysial CT, muscles replaced by fat and CT, involves type I and type II fibers**.
* _presentation_: **by age 5, wheelchair by 10-12. death in early 20's.**
* **weakness in pelvic girdle muscles**
* **pseudohypertrophy**: lower muscles hypertrophied with weakness.
* **heart failure and arrhythmia**, risk of **cardiomyopathy**
* **cognitive impairment**
* death from **respiratory insufficiency, pulmonary infection, cardiac decompensation**.
207
**Becker Muscular Dystrophy**
* **X-linked** muscular dystrophy.
* starts later than DMD, not as severe.
* mutated **DMD gene at Xp21** encoding dystrophin
* 2/3 familial, 1/3 de novo.
* **↓ amounts dystrophin that has abnormal molecular weight**.
* _morphology_: **variations in myofiber diameter, ↑ internalized nuclei, degeneration/necrosis/phagocytosis of muscle fibers, regenerated muscle fibers, proliferation of endomysial CT, muscle replaced by fat and CT, type I and type II fibers involved.**
* _presentation_: **weakness in pelvic girdle muscles, pesudohypertrophy, heart failure and arrhythmia, cardiomyopathy, cognitive impairment**.
* death by **respiratory insufficiency, pulmonary infection, cardiac decompensation**.
208
**Limb Girdle Muscular Dystrophy**
* **autosomal** muscular dystrophy.
* affects **proximal trunk and limb musculature**.
* **mutations of transmembrane sarcoglycan complex of proteins** that link dystrophin with ECM.
209
**Myotonic Dystrophy**
* **autosomal dominant**
* ↑ in severity and appear at younger age in successive generations = **anticipation**.
* **myotonia** = sustained involuntary muscle contraction. cardinal neuromuscular symptom.
* _pathogenesis_: **CTG trinucleotide repeat** expansion on **19q13**. affects mRNA for DMPK.
* _morphology_: **fiber size heterogeneity, ↑ numbers internal nuclei and ring fibers** (subsarcolemmal band of cytoplasm with rim of myofibrils that wrap around longitudinally oriented fibrils).
* changes in muscle spindles: **fiber splitting, necrosis, regeneration.**
* _presentation_: **abnormalities in gait from foot dorsiflexor weakness, weakness in intrinsic hand muscles and wrist extensors, facial muscle atrophy, ptosis.**
* **cataracts, frontal balding, gonadal atrophy, cardiomyopathy, smooth muscle involvement, ↓ plasma IgG, abnormal glucose tolerance test**.
210
**Channelopathies**
* **familial** disease with **myotonia and/or hypotonic palsies**
* hypotonic can be hyper, hypo, or normokalemic.
* **_hyperkalemic periodic paralysis_**: mutated **SCN4A sodium channel protein** - regulates Na entry during muscle contraction.
* **_hypokalemic periodic paralysis_**: mutated gene for **voltage gated L-type Ca channel**.
* **_malignant hyperpyrexia_** (malignant hyperthermia): dramatic **hypermetabolic state triggered by anesthesia**. mutated gene for **voltage gated L-type Ca channel** (ryanodine receptor).
* anesthetic ⇒ uncontrolled sarcoplasmic Ca efflux ⇒ **tetany, ↑ muscle metabolism, excess heat production**.
* tachycardia, tachypnea, muscle spasms, hyperpyrexia later.
211
**Fascioscapulohumeral Muscular Dystrophy**
* **autosomal dominant**.
* **_type 1A_**: deletions from **D4Z4** on 4q35.
* **_type 1B_**: mutated **FSHMD1B**.
* _morphology_: **dystropic myopathy with inflammatory infiltrates in muscle**.
* _presentation_: age **10-30yrs**, **weakness of muscles of face, neck, shoulder girdle.**
212
**Oculopharyngeal Muscular Dystrophy**
* **autosomal dominant**
* mutated **PABP-2** gene.
* _morphology_; dystrophic myopathy with **rimmed vacuoles in type 1 fibers**.
* _presentation_: onset in **mid adult life**, **ptosis and weakness of extraocular muscles, difficulty swallowing.**
213
**Emery-Dreifuss Muscular Dystrophy**
* **X-linked**.
* mutated **emerin (EMD1)** gene
* _morphology_: **mild myopathic changes, absent emerin**.
* _presentation_: onset **10-20yrs**, prominent **contractures especially at elbows and ankles**.
214
**Congenital Muscular Dystrophies**
* **autosomal recessive**
* three types: **_MDC1A_** = type 1a, **merosin** deficient (**laminin alpha 2** gene).
* **_MDC1B_** = type 1b, **1q42**.
* **_MDC1c_** = type 1c, **fukutin** related protein gene.
* _morphology_: **variable fiber size, extensive endomysial fibrosis.**
* _presentation_: **neonatal hypotonia, respiratory insufficiency, delayed motor milestones**.
215
**Congenital Muscular Dystrophy with CNS Manifestations**
* aka **Fukuyama** type.
* **autosomal recessive**.
* mutated **fukutin**.
* _morphology_: **variable muscle fiber size and endomysial fibrosis, CNS malformations** (polymicrogyria)
* _presentation_: **neonatal hypotonia and mental retardation.**
216
**Congenital Muscular Dystrophy with CNS and Ocular Manifestations**
* aka **Walker-Warburg** type.
* mutated **POMT1, POMT2**.
* _morphology_: **variable muscle fiber size and endomysial fibrosis, CNS and ocular malformations**
* _presentation_: **neonatal hypotonia and mental retardation with cerebral and ocular malformations**.
217
**Lipid Myopathies**
* abnormalities of **carnitine transport system** or deficiency of **mitochondrial dehydrogenase enzyme systems** ⇒ **block fatty acid catabolism, muscle lipid accumulation**.
* **limited ATP generation** when exercising ⇒ **pain, tightness, myoglobinuria.**
* can have **cardiomyopathies** and **fatty liver**.
218
**Mitochondrial Myopathies**
* oxidative phosphorylation diseases.
* from mutations in nuclear and mitochondrial genes.
* _morphology_: **aggregates of abnormal mitochondria** ⇒ irregular muscle fiber contour (**ragged red fibers**),
* **↑ # and abnormalities in shape and size of mitochondria**.
* may contain **paracrystalline arrays** (parking lot inclusions) or **alterations in cristae structure**.
* _presentation_: **young adults, proximal muscle weakness, severe eye muscle dysfunction**. **neurologic symptoms, lactic acidosis, cardiomyopathy**.
* from mtDNA mutation have **maternal inheritance**.
* from **pt mutations in mtDNA** ⇒ myoclonic epilepsy, Leber hereditary optic neuropathy, MELAS.
* from **deletions or duplications of mtDNA** ⇒ chronic progressive external ophthalmoplegia or Kearns-Sayer syndrome.
* from **mutated nuclear DNA** = X-linked or autosomal dominant/recessive. subacute necrotizing encephalopathy, exertional myoglobinuria, X-linked cardioskeletal myopathy.
219
**Central Core Disease**
* **autosomal dominant**
* mutation **RYR1** gene.
* _morphology_: **cytoplasmic cores slightly eosinophilic and distinct from sarcoplasm**. in **type I fibers** on NADH stain.
* _presentation_: **early onset hypotonia, nonprogressive weakness, skeletal deformities**, sometimes **malignant hyperthermia**.
220
**Nemaline Myopathy**
* **autosomal dominant or recessive**.
* dominant = **NEM1-TPM3 gene** (tropomysin 3)
* recessive = **NEM2-NEB gene** (nebulin)
* dominant or recessive = **ACTA1 gene** (skeletal muscle actin alpha 1)
* _morphology_: aggregates of **nemaline rods** (subsarcolemmal spindle-shaped particles), in **type I fibers**, from **alpha-actinin in Z-band**. see on **Gomori** stain.
* _presentation_: **weakness, hypotonia, delayed motor development in childhood** (sometimes adults).
* **nonprogressive**.
* involves **proximal limb muscles** most.
* can have skeletal abnormalities.
221
**Myotubular Myopathy**
* aka centronuclear.
* X-linked, autosomal dominant, autosomal recessive.
* X-linked = **MTM1** gene.
* autosomal dominant = **MYF6** gene
* autosomal recessive = unknown.
* _morphology_: abundance of **centrally located nuclei involving majority of muscle fibers**, in **type I fibers with small diameter**, can be in type II fibers.
* _presentation_: **_X-linked_**: **infancy with hypotonia, poor prognosis.**
* **_autosomal_** = **limb weakness, slowly progressive.**
* recessive = intermediate in severity and prognosis.
222
**Dermatomyositis**
* **lilac discoloration of upper eyelids and periorbital edema** before or with weakness.
* **Grotton lesions** = scaling, erythematous patches over knuckles, elbows, knees.
* **slow onset** muscle weakness, **bilaterally symmetric**, **proximal muscles first**.
* **dysphagia** in 1/3.
* may have **interstitial lung disease, vasculitis, myocarditis**.
* **25% have cancer**.
* _juvenile pts_: **GI symptoms**, 1/3 have **calcinosis**.
* **targets capillaries**.
* _morphology_: **perivascular inflammatory infiltrates**, scattered **necrotic muscle fibers** and **muscle fiber atrophy at periphery of fascicles** from **hypoperfusion**.
* _tx_: immunosuppression.
223
**Polymyositis**
* in **adults**.
* **cytotoxic T cell driven** myocyte damage
* **autoAb against tRNA synthetases**.
* **slow onset** muscle weakness, **bilaterally symmetric**, **proximal muscles first**.
* _morphology_: **endomysial inflammation, scattered necrotic muscle fibers, no vascular injury** (perifascicular atrophy)
* tx: immunosuppression.
224
**Inclusion Body Myositis**
* starts with **distal muscle involvement (extensors of knee, flexors of wrist).**
* can be **asymmetric**.
* **insidious** onset, **age \> 50 yrs**.
* CD8+ T cells present but **immunosuppression not effective.**
* intracellular deposits of **beta-amyloid** and **hyperphosphorylated tau** = **abnormal protein folding.**
* _morphology_: **endomysial inflammatory infiltrates**, **rimmed vacuoles** (clear cytoplasm with thin rim basophilic material), contain **amyloid**.
225
**Thyrotoxic Myopathy**
* **proximal muscle weakness**, can precede clinical thyroid dysfunction.
* **myofiber necrosis, regeneration, interstitial lymphocytosis.**
* **_hypothyroidism_**: **muscle cramping and slow movements from fiber atrophy, ↑ # internal nuclei, glycogen aggregates.**
226
**Ethanol Myopathy**
* binge drinking ⇒ **acute toxic syndrome of rhabdomyolysis with myoglobulinemia**.
* can cause **renal failure**.
227
**Drug-Induced Myopathies**
* **_Cushing syndrome or corticosteroids_** ⇒ **proximal muscles weakness** and atrophy in **type II fibers**
* **_chloroquine _**⇒ **proximal myopathy** with **autophagic membrane-bound vacuoles** and **intracellular curvilinear lamellar bodies.**
* **_Statin-induced myopathy_** in 1-2%.
228
**Myasthenia Gravis**
* **autoAb against skeletal muscle Ach receptors**.
* **women \< 40 yrs**. m=f in elderly.
* _pathogenesis_: AchR autoAb ⇒ c**omplement fixation and direct postsynaptic membrane damage, accelerate internalization and down-regulation of AchR, or block Ach binding.**
* _morphology_: LM **unremarkable**, **junctional folds reduced or gone at NMJ, ↓ AchR expression**.
* _Presentation_: **easy fatigability, ptosis, and diplopia**. worsen with repeated stimulation.
* **thymic hyperplasia** in 65%.
* **thymomas** in 15%.
* thymic resection can improve it.
* _tx_: anticholinesterase agents, prednisone, plasmapheresis.
229
**Lambert-Eaton Myasthenic Syndrome**
* **weakness and autonomic dysfunction**.
* mostly paraneoplastic from **small cell lung carcinoma**.
* **autoAb against pre-synaptic voltage gated Ca channel** ⇒ **↓ amount synaptic vesicles released**.
* **improves with repeated stimulation**.